Continuous Glucose Monitoring and Inflammation in Nondiabetic and Diabetic Patients Undergone Hemodialysis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Diabetes
- Sponsor
- University of Pavia
- Enrollment
- 36
- Locations
- 1
- Primary Endpoint
- -Hemodialysis tolerability -Hypoglycemia numbers -Hyperglycemia numbers -Inflammation markers
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
Evaluation of different glycemic variations between the dialysis period and non-dialysis period in two groups: nondiabetic and diabetic patients undergone two different hemodialysis methods. Thirty-six patients, males and females, aged 50-80 years, with end stage renal disease (ESRD) will undergo hemodialysis and continuous glucose monitoring (CGM). The investigators will evaluate also inflammation markers before and after the different hemodialysis methods.
Investigators
Giuseppe Derosa
Professor
University of Pavia
Eligibility Criteria
Inclusion Criteria
- •patients with or without diabetes mellitus
- •undergone hemodialysis
- •males and females aged 50-80
Exclusion Criteria
- •chronic inflammation diseases
- •acute pulmonary diseases
Outcomes
Primary Outcomes
-Hemodialysis tolerability -Hypoglycemia numbers -Hyperglycemia numbers -Inflammation markers
Time Frame: before and after each procedure
Secondary Outcomes
- variations of glycemia during the night; insulin-sensitivity(at the beginning of the first hemodialysis and at the end of the second hemodialysis)